Grufity logo
Grufity logo

Latest Nantahala Capital Management, LLC Stock Portfolio

$2.72Billion– No. of Holdings #129

Nantahala Capital Management, LLC Performance:
2026 Q1: -7.73%YTD: -7.73%2025: 21.8%
Performance for 2026 Q1 is -7.73%, and YTD is -7.73%, and 2025 is 21.8%.

About Nantahala Capital Management, LLC and 13F Hedge Fund Stock Holdings

Nantahala Capital Management, LLC is a hedge fund based in New Canaan, CT. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Nantahala Capital Management, LLC reported an equity portfolio of $2.7 Billions as of 31 Mar, 2026.

The top stock holdings of Nantahala Capital Management, LLC are TBBK, HGV, SLNO. The fund has invested 2.7% of it's portfolio in BANCORP INC DEL and 2.2% of portfolio in HILTON GRAND VACATIONS INC.

The fund managers got completely rid off EVENTBRITE INC (EB), RAPT THERAPEUTICS INC (RAPT) and GLOBUS MED INC (GMED) stocks. They significantly reduced their stock positions in DIANTHUS THERAPEUTICS INC, UNIQURE NV (QURE) and TANGO THERAPEUTICS INC (TNGX). Nantahala Capital Management, LLC opened new stock positions in VAXCYTE INC (PCVX), AGOMAB THERAPEUTICS NV and JANUX THERAPEUTICS INC (JANX). The fund showed a lot of confidence in some stocks as they added substantially to MONTE ROSA THERAPEUTICS INC (GLUE), MINERALYS THERAPEUTICS INC and VERASTEM INC (VSTM).
Nantahala Capital Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2026

Nantahala Capital Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Nantahala Capital Management, LLC made a return of -7.73% in the last quarter. In trailing 12 months, it's portfolio return was 28.68%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
vaxcyte inc13,873,500
agomab therapeutics nv12,852,000
helix acquisition corp iii12,700,000
janux therapeutics inc11,257,800
duolingo inc9,857,000
damora therapeutics inc7,200,200
venu hldg corp6,774,590
alector inc6,054,360
New stocks bought by Nantahala Capital Management, LLC

Additions

Ticker% Inc.
monte rosa therapeutics inc1,024
mineralys therapeutics inc690
verastem inc675
keros therapeutics inc277
camping world hldgs inc207
anteris technologies global118
peloton interactive inc102
vyne therapeutics inc100
Additions to existing portfolio by Nantahala Capital Management, LLC

Reductions

Ticker% Reduced
dianthus therapeutics inc-82.06
disc medicine inc-80.68
uniqure nv-66.1
tango therapeutics inc-65.00
opus genetics inc-64.84
pepgen inc-55.98
cg oncology inc-54.82
immunic inc-42.75
Nantahala Capital Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
eventbrite inc-30,503,500
anebulo pharmaceuticals inc-3,066,690
astria therapeutics inc-14,000,100
rapt therapeutics inc-25,543,200
nuvation bio inc-206,643
edesa biotech inc-887,500
noodles & co-2,912,040
columbus mckinnon corp n y-7,762,500
Nantahala Capital Management, LLC got rid off the above stocks

Sector Distribution

Nantahala Capital Management, LLC has about 47.4% of it's holdings in Healthcare sector.

  • Healthcare
  • Consumer Cyclical
  • Others
  • Financial Services
  • Communication Services
  • Industrials
  • Consumer Defensive
  • Real Estate
  • Technology
  • Basic Materials
Sector%
Healthcare47.4
Consumer Cyclical16.5
Others16.4
Financial Services4.8
Communication Services4.3
Industrials2.9
Consumer Defensive2.7
Real Estate2.4
Technology1.2
Basic Materials1.1

Market Cap. Distribution

Nantahala Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • MID-CAP
  • MICRO-CAP
  • UNALLOCATED
  • NANO-CAP
Category%
SMALL-CAP41
MID-CAP21.6
MICRO-CAP18.9
UNALLOCATED16.2
NANO-CAP2

Stocks belong to which Index?

About 50.9% of the stocks held by Nantahala Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200050.9
Others48.9
Top 5 Winners (%)%
KOS
kosmos energy ltd
184.4 %
PHGE
biomx inc
100.8 %
ASRT
assertio holdings inc
93.9 %
TNGX
tango therapeutics inc
91.9 %
OCUP
opus genetics inc
85.4 %
Top 5 Winners ($)$
TNGX
tango therapeutics inc
29.1 M
BVS
bioventus inc
10.3 M
dianthus therapeutics inc
9.4 M
ETON
eton pharmaceuticals inc
9.1 M
RYAM
rayonier advanced matls inc
8.8 M
Top 5 Losers (%)%
fractyl health inc
-77.5 %
EHTH
ehealth inc
-72.0 %
upstream bio inc
-60.4 %
GFAI
guardforce ai co ltd
-60.0 %
PEPG
pepgen inc
-52.4 %
Top 5 Losers ($)$
fractyl health inc
-21.1 M
SLNO
soleno therapeutics inc
-19.6 M
TBBK
bancorp inc del
-16.9 M
PTON
peloton interactive inc
-16.8 M
EOLS
evolus inc
-15.5 M

Nantahala Capital Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Nantahala Capital Management, LLC

Nantahala Capital Management, LLC has 129 stocks in it's portfolio. About 18.3% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. TNGX was the most profitable stock for Nantahala Capital Management, LLC last quarter.

Last Reported on: 15 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions